U.S. Inflammatory Bowel Disease Treatment Market Trends Analysis Report 2024-2030 Featuring Biogen, Novartis, Eli Lilly & Co, UCB, Celltrion, Merck & Co, and Johnson & Johnson
June 25, 2024 10:57 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "U.S. Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report by Type, Drug Class, Route Of Administration, Distribution...
Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Outlook 2024-2028: Product Innovations and Strategic Partnerships Catalyzing Industry Growth
January 23, 2024 11:48 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The tumor necrosis...
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilization of IL-17 Inhibitors
January 22, 2024 10:47 ET
|
Spherix Global Insights
EXTON, PA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Since the first US FDA-approved tumor necrosis factor (TNF) inhibitor in 2002 for the treatment of psoriatic arthritis (PsA), TNF’s have upheld their...
Consecutive Use of TNF-Inhibitors for the Treatment of Psoriatic Arthritis at Lowest Point Recorded, as Use of Biologics with Alternate Mechanisms of Actions Continue to Grow, According to Spherix Global Insights
October 03, 2023 13:57 ET
|
Spherix Global Insights
Exton, Pennsylvania, Oct. 03, 2023 (GLOBE NEWSWIRE) -- US rheumatologists (n=204) report nearly two-thirds of their psoriatic arthritis (PsA) patients are undergoing treatment with advanced systemic...
Global Axial Spondyloarthritis Treatment Market Report 2023: Surge in Incidences of Axial Spondylarthritis Drives Growth
June 26, 2023 05:53 ET
|
Research and Markets
Dublin, June 26, 2023 (GLOBE NEWSWIRE) -- The "Axial Spondyloarthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added to ...
Global Tumor Necrosis Factor Inhibitor Drugs Market Report 2023: Increasing Prevalence of Autoimmune Illness Bolsters Growth
June 07, 2023 07:23 ET
|
Research and Markets
Dublin, June 07, 2023 (GLOBE NEWSWIRE) -- The "Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Global Inflammatory Bowel Disease Market Report 2021: Market was Valued at $210.5 Billion in 2020 - Forecast to 2026
May 12, 2021 08:13 ET
|
Research and Markets
Dublin, May 12, 2021 (GLOBE NEWSWIRE) -- The "Global Inflammatory Bowel Disease (IBD) Market - Analysis By Disease Indication (Crohn's Disease, Ulcerative Colitis), Drug Class, Distribution Channel,...
Global Rheumatoid Arthritis (RA) Market Analysis & Drug Forecasts, 2019-2029 - Late-Stage RA Pipeline Holds Promise But Likely Won't Match the Utility of JAK Inhibitors
January 12, 2021 04:08 ET
|
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. Global revenues...
Global Psoriatic Arthritis Drug Forecast and Market Analysis to 2028: Oral Therapeutics Dominate the Late-Stage PsA Pipeline
November 09, 2020 07:48 ET
|
Research and Markets
Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028" report has been added to ResearchAndMarkets.com's offering. Current therapies...
Rheumatoid Arthritis in 7 Major Markets 2017-2030: United States, Germany, France, Italy, Spain, United Kingdom and Japan
September 02, 2020 05:24 ET
|
Research and Markets
Dublin, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. ...